{"pmid":32299328,"title":"Novel Coronavirus (COVID-19): What You Need to Know.","text":["Novel Coronavirus (COVID-19): What You Need to Know.","Much remains unknown about COVID-19. Occupational health nurses must use reliable sources to control misinformation and prevent widespread panic.","Workplace Health Saf","Carver, Pamela E","Phillips, Jennan","32299328"],"abstract":["Much remains unknown about COVID-19. Occupational health nurses must use reliable sources to control misinformation and prevent widespread panic."],"journal":"Workplace Health Saf","authors":["Carver, Pamela E","Phillips, Jennan"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299328","week":"202016|Apr 13 - Apr 19","doi":"10.1177/2165079920914947","keywords":["2019 ncov","mers","sars","coronavirus","occupational health nurses","respiratory illness"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664357978509148160,"score":8.233237,"similar":[{"pmid":31992543,"title":"The coronavirus outbreak: the central role of primary care in emergency preparedness and response.","text":["The coronavirus outbreak: the central role of primary care in emergency preparedness and response.","BJGP Open","Dunlop, Catherine","Howe, Amanda","Li, Donald","Allen, Luke N","31992543"],"journal":"BJGP Open","authors":["Dunlop, Catherine","Howe, Amanda","Li, Donald","Allen, Luke N"],"date":"2020-01-30T11:00:00Z","year":2020,"_id":"31992543","week":"20205|Jan 27 - Feb 02","doi":"10.3399/bjgpopen20X101041","keywords":["Infectious illness","coronavirus","general practice","health promotion and prevention","primary health care","respiratory illness"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352134850052097,"score":81.901436},{"pmid":32245083,"title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["COVID-19","Coronavirus","SARS","SARS-CoV-2","Wuhan","pandemic"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1663352135817887744,"score":79.491165},{"pmid":32234465,"pmcid":"PMC7118423","title":"Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","text":["Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection.","Int J Antimicrob Agents","Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun","32234465"],"abstract":["Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection."],"journal":"Int J Antimicrob Agents","authors":["Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234465","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105950","keywords":["Detection","Mechanism","Novel coronavirus","Treatment"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1663352135478149120,"score":66.52671},{"pmid":32292622,"pmcid":"PMC7102575","title":"Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers.","text":["Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers.","Coronavirus disease 2019 (COVID-19) poses an occupational health risk to healthcare workers. Several thousand healthcare workers have already been infected, mainly in China. Preventing intra-hospital transmission of the communicable disease is therefore a priority. Based on the Systems Engineering Initiative for Patient Safety model, the strategies and measures to protect healthcare workers in an acute tertiary hospital are described along the domains of work task, technologies and tools, work environmental factors, and organizational conditions. The principle of zero occupational infection remains an achievable goal that all healthcare systems need to strive for in the face of a potential pandemic.","Saf Health Work","Hoe Gan, Wee","Wah Lim, John","Koh, David","32292622"],"abstract":["Coronavirus disease 2019 (COVID-19) poses an occupational health risk to healthcare workers. Several thousand healthcare workers have already been infected, mainly in China. Preventing intra-hospital transmission of the communicable disease is therefore a priority. Based on the Systems Engineering Initiative for Patient Safety model, the strategies and measures to protect healthcare workers in an acute tertiary hospital are described along the domains of work task, technologies and tools, work environmental factors, and organizational conditions. The principle of zero occupational infection remains an achievable goal that all healthcare systems need to strive for in the face of a potential pandemic."],"journal":"Saf Health Work","authors":["Hoe Gan, Wee","Wah Lim, John","Koh, David"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292622","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.shaw.2020.03.001","keywords":["Coronavirus disease 2019","SEIPS","occupational health"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295774806016,"score":64.92011},{"pmid":32191830,"title":"COVID-19 - what should anaethesiologists and intensivists know about it?","text":["COVID-19 - what should anaethesiologists and intensivists know about it?","Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.","Anaesthesiol Intensive Ther","Wujtewicz, Magdalena","Dylczyk-Sommer, Anna","Aszkielowicz, Aleksander","Zdanowski, Szymon","Piwowarczyk, Sebastian","Owczuk, Radoslaw","32191830"],"abstract":["Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus."],"journal":"Anaesthesiol Intensive Ther","authors":["Wujtewicz, Magdalena","Dylczyk-Sommer, Anna","Aszkielowicz, Aleksander","Zdanowski, Szymon","Piwowarczyk, Sebastian","Owczuk, Radoslaw"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32191830","week":"202012|Mar 16 - Mar 22","doi":"10.5114/ait.2020.93756","keywords":["* COVID-19","* SARS-CoV-2","* acute respiratory distress syndrome (ARDS)","* acute pneumonia","* infection","*viruses"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352133750095872,"score":61.985043}]}